Usz Remedium Private Limited - Company Profile

It is a manufacturing private limited company based in Srinagar, Jammu & Kashmir, India, established in 2019.
2019 Srinagar, Jammu & Kashmir, India Active
Last Updated:
Access Report
About Usz Remedium Private Limited

Usz Remedium Private Limited, a active private limited company, was established on 04 February 2019 in Srinagar, Jammu & Kashmir, India. Engaging in manufacturing within the manufacturing sector, it holds CIN: U36900JK2019PTC010819. Registered under ROC Roc Jammu. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹30.00 K .

It upholds a compliant status. Its leadership includes Zubair Hamid Dar (Director), Shafaat Ahmed Siddiqi (Managing Director), Usman Gani (Director). It is based at House No. 31, Near Jamia Alhadees Masjid Kursoo, Rajbagh, Srinagar, Jammu & Kashmir, 190008.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U36900JK2019PTC010819

  • Registration Number

    010819

  • Incorporation Date

    04 February 2019

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹30.00 K

  • ROC Code

    Roc Jammu

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 30.00 K
  • Company Age 7 Year, 1 Month
Company report

Usz Remedium Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Usz Remedium Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Usz Remedium Private Limited?
Current Directors
Name Designation Appointment Date Status
Zubair Hamid Dar Director 04 Feb 2019 Current
Shafaat Ahmed Siddiqi Managing Director 04 Feb 2019 Current
Usman Gani Director 04 Feb 2019 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Usz Remedium.

Enhance accessibility to Usz Remedium's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Usz Remedium revenue growth over time
Usz Remedium profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Usz Remedium?

Unlock access to Usz Remedium's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Usz Remedium?

Unlock and access historical data on people associated with Usz Remedium, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Usz Remedium, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Usz Remedium's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Usz Remedium
Recent Activity within the Organization
  • Director Appointment

    Progress on Zubair Hamid Dar was appointed as a Director was appointed as a Director on 04 Feb 2019 & has been associated with this company since 7 years 1 month . was documented.

  • Director Appointment

    Shafaat Ahmed Siddiqi was appointed as a Managing Director was appointed as a Managing Director on 04 Feb 2019 & has been associated with this company since 7 years 1 month . was recorded as a recent event.

  • Director Appointment

    Usman Gani was appointed as a Director was appointed as a Director on 04 Feb 2019 & has been associated with this company since 7 years 1 month . was recorded as a recent event.

  • Company Incorporation

    Progress on Usz Remedium Private Limited was registered on 04 Feb 2019 with Roc Jammu & aged 7 years 1 month as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Usz Remedium Private Limited?

The CIN of Usz Remedium Private Limited is U36900JK2019PTC010819.

Where is Usz Remedium Private Limited headquartered?

Usz Remedium Private Limited is headquartered at House No. 31, Near Jamia Alhadees Masjid Kursoo, Rajbagh, Srinagar, Jammu & Kashmir, 190008.

When was Usz Remedium Private Limited incorporated?

Usz Remedium Private Limited was incorporated on 04 February 2019.

Who are the current directors of Usz Remedium Private Limited?

The current directors of Usz Remedium Private Limited are

What is the primary industry of Usz Remedium Private Limited?

The primary industry of Usz Remedium Private Limited is Manufacturing.

Is Usz Remedium Private Limited a listed company?

Usz Remedium Private Limited is unlisted.

What is the capital structure of Usz Remedium Private Limited?

The authorized capital of Usz Remedium Private Limited is ₹1.00 M, and the paid-up capital is ₹30.00 K .

What is the compliance status of Usz Remedium Private Limited?

The compliance status of Usz Remedium Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available